borderline ovarian tumor

bor·der·line ovarian tu·mor

an ovarian surface epithelial tumor in which the growth pattern is intermediate between benign and malignant; includes mucinous, serous, endometrioid, and Brenner tumors of the ovary; highly curable but may recur after surgical removal.

bor·der·line o·var·i·an tu·mor

(bōr'dĕr-līn ō-var'ē-ăn tū'mŏr)
An ovarian surface epithelial tumor in which the growth pattern is intermediate between benign and malignant; includes mucinous, serous, endometrioid, and Brenner tumors of the ovary; highly curable but may recur after surgical removal.
References in periodicals archive ?
KEY WORDS: Borderline ovarian tumor, FIGO, Mucinous ovarian tumor, Serous ovarian tumor.
Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor.
Port-site metastasis of mucinous borderline ovarian tumor after laparoscopy.
The serum CA-125 concentration data assists in evaluating CT imaging information when used to differentiate borderline ovarian tumor from malignant epithelial ovarian tumors.
The final histologic findings demonstrated Demons' pseudosyndrome which is an unusual situation when it's related to a borderline ovarian tumor (8).
Accuracy for diagnosing a borderline ovarian tumor by imprint cytology is 66.
A patient with a borderline ovarian tumor may have pain, bloating, or have just a pressure sensation.
Other similar study conducted by Rettenmaier et al11 has also reported a higher proportion (nearly 20%) of borderline ovarian tumors.
Of the two Borderline Ovarian Tumors (BOT), two were Serous subtype.
Oncologists, obstetricians and gynecologists, and other physicians from North America and Europe address the prevention, features, management, diagnosis, and multidisciplinary approach to cervical cancer and precancerous lesions, uterine cancer, epithelial ovarian cancer, borderline ovarian tumors, germ cell tumors of the ovary, cancer of the vulva, and gestational trophoblastic disease, and future directions in treatment, including laparoscopy and robotic-assisted surgery, innovations in radiotherapy, hormonal treatment, biomarkers, integrative medicine, and multidisciplinary palliative care.
Results from a large Dutch cohort study of 25,152 women using linked medical records to identify women who had been seen for infertility and/or treated with IVF from 1983 to 1995 showed that borderline ovarian tumors accounted for most of the increase in risk after a median 15 years of follow-up.
Exacoustos and colleagues found that papillae as large as 15 mm in height and 10 mm in width (base) were present in 48% of borderline ovarian tumors but in only 4% of benign and 4% of malignant tumors.
Full browser ?